Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126180751 | 12618075 | 1 | I | 20160708 | 20160715 | 20160803 | 20160803 | PER | US-JNJFOC-20160718340 | JANSSEN | 34.93 | YR | A | F | Y | 52.16000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126180751 | 12618075 | 1 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | N | 467842 | 0 | 10 | MG | TABLET | QD | |||||
| 126180751 | 12618075 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | N | 467842 | 0 | 10 | MG | TABLET | QD | |||||
| 126180751 | 12618075 | 3 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | N | 467842 | 19835 | 10 | MG | TABLET | QD | |||||
| 126180751 | 12618075 | 4 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | N | 467842 | 19835 | 10 | MG | TABLET | QD | |||||
| 126180751 | 12618075 | 5 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126180751 | 12618075 | 6 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126180751 | 12618075 | 7 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126180751 | 12618075 | 8 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126180751 | 12618075 | 1 | Eye swelling |
| 126180751 | 12618075 | 2 | Cheilitis |
| 126180751 | 12618075 | 3 | Burning sensation |
| 126180751 | 12618075 | 4 | Hypersensitivity |
| 126180751 | 12618075 | 5 | Eye swelling |
| 126180751 | 12618075 | 6 | Cheilitis |
| 126180751 | 12618075 | 7 | Burning sensation |
| 126180751 | 12618075 | 8 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126180751 | 12618075 | Off label use | |
| 126180751 | 12618075 | Product use issue | |
| 126180751 | 12618075 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126180751 | 12618075 | 1 | 20160708 | 0 | ||
| 126180751 | 12618075 | 2 | 20160708 | 0 | ||
| 126180751 | 12618075 | 3 | 20160708 | 0 | ||
| 126180751 | 12618075 | 4 | 20160708 | 0 |